Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Energy-efficient technology to meet both regulatory and ESG goals
These doses are well tolerated and have no meaningful toxicity risk, as excess B12 is excreted in urine rather than accumulating in tissues
In the published Phase 1/2 trial, CJC-1295 with DAC showed no serious adverse events at doses up to 60 mcg/kg
Youll inject it just under your skin into one of three injection sites: your stomach, upper thigh, or upper arm
Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment
US$ 27.90
US$ 22.27
US$ 22.68
US$ 25.37
US$ 27.09
